CMA closes probe into three Concordia drugs - Global Competition Review

Global Competition Review
CMA closes probe into three Concordia drugs
Global Competition Review
The UK's competition enforcer has shuttered part of its antitrust probe of drugmaker Concordia after deciding it did not have the need or resources to continue investigating three of the company's drugs.